SIRT2 promotes BRCA1-BARD1 heterodimerization through deacetylation.

Area of Science:

• Molecular Biology
• Genetics
• Biochemistry

Background:

• The breast cancer type I susceptibility protein (BRCA1) and BRCA1-associated RING domain protein I (BARD1) heterodimer are crucial for maintaining genome integrity and DNA repair via homologous recombination (HR).
• BRCA1-BARD1 heterodimerization is essential for their stability, function in HR, and tumor suppression, but the upstream regulatory mechanisms remain largely unknown.

Purpose of the Study:

• To investigate the upstream signaling pathways that regulate BRCA1-BARD1 heterodimerization.
• To elucidate the role of SIRT2, a known breast tumor suppressor, in the regulation of BRCA1-BARD1 complex formation and function.

Main Methods:

• Co-immunoprecipitation assays to detect protein-protein interactions.
• In vitro deacetylation assays using purified SIRT2 and BARD1.
• Western blotting to assess protein stability and localization.
• Immunofluorescence microscopy to visualize protein localization at DNA damage sites.

Main Results:

• SIRT2 directly interacts with the BRCA1-BARD1 complex.
• SIRT2 deacetylates specific lysine residues within the BARD1 RING domain, adjacent to the BRCA1-binding interface.
• Deacetylation by SIRT2 promotes stable BRCA1-BARD1 heterodimerization.
• This process enhances BRCA1-BARD1 nuclear retention and localization to sites of DNA double-strand breaks (DSBs).

Conclusions:

• SIRT2 acts as a key regulator of BRCA1-BARD1 heterodimerization through deacetylation.
• This SIRT2-mediated mechanism is critical for efficient homologous recombination repair and tumor suppression.
• The findings reveal a novel role for SIRT2 in directing DNA double-strand break repair pathways.